Levi Strauss and Co Class A (LEVI)
Live price chart, market sentiment, and community perspectives for Levi Strauss and Co Class A (NYSE: LEVI).
Live price chart, market sentiment, and community perspectives for Levi Strauss and Co Class A (NYSE: LEVI).
On our desk, LEVI's Q1 performance caught our attention with net revenues hitting $1.742 billion and adjusted diluted EPS beating expectations at $0.42. The company's pivot toward a denim lifestyle brand is yielding clear outperformance in the women's business and tops categories, both up 13%. Furthermore, DTC now comprises 52% of total revenues with e-commerce up 21% reported. Management's decision to raise 2026 guidance for revenue, margins, and EPS provides a solid fundamental floor, even as we monitor structural headwinds like soft constant-currency growth flagged by third-party research.
Reviewing the risk disclosures in the latest SEC filings, I am keeping a close eye on their tariff and supply chain assumptions. Their fiscal 2026 guidance explicitly relies on U.S. tariffs remaining at 30% for China and 20% for the Rest-of-World, alongside locked ocean freight and cotton rates through 2026. Additionally, with $240 million remaining under their share repurchase authorization and consistent quarterly cash dividend distributions of $0.14 per share, capital allocation remains shareholder-friendly, though broader market volatility continues to constrain multiple expansion.
Watching the technical indicators from a quantitative standpoint, LEVI's RSI(14) sits at a neutral 57.79, while the Stochastic Oscillator at 74.07 and STOCHRSI at 68.78 show a balanced market sentiment with no extreme buying or selling pressure. The Average Directional Index (ADX) of 17.24 further confirms that there is currently no clear directional movement, indicating the stock is trading sideways within its mid-cap range. Analysts maintain a consensus price target averaging around $25.83, suggesting a moderate upside from current trading levels.
Explore plasma cleansing, somatic organ swaps, and BCI.